MSCopilot® can classify patients according to their disability levels in Multiple Sclerosis

We presented new analyses from MSCopilot® at the CHARCOT Congress held in November 2025 in Baveno, Italy. This medical device stands out for its clinically validated ability to classify patients with multiple sclerosis (MS) according to their level of disability. Its digital biomarkers make it possible to assess varioussymptoms in real-life conditions, providing a score that has been previously shown to correlate with the Expanded Disability Status Scale (EDSS).